One year since Zimmer Biomet signed the agreement to acquire the medical device company, Embody has continued to operate, selling its patented Tapestry implants for tendon and ligament repair and arthroscopy.
However, since the acquisition, Embody has not debuted any new devices or implants on its website. The company’s CEO, Jeffrey Conroy, has remained unchanged since Zimmer Biomet’s acquisition.
Zimmer Biomet now holds Embody’s patents for the Tapestry implant, according to a 2023 update to its website.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
